BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 11879566)

  • 1. The role of cytokines in regulating estrogen synthesis: implications for the etiology of breast cancer.
    Purohit A; Newman SP; Reed MJ
    Breast Cancer Res; 2002; 4(2):65-9. PubMed ID: 11879566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of nomegestrol acetate on estrogen biosynthesis and transformation in MCF-7 and T47-D breast cancer cells.
    Shields-Botella J; Chetrite G; Meschi S; Pasqualini JR
    J Steroid Biochem Mol Biol; 2005 Jan; 93(1):1-13. PubMed ID: 15748827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzymatic control of estrogen production in human breast cancer: relative significance of aromatase versus sulfatase pathways.
    Santen RJ; Leszczynski D; Tilson-Mallet N; Feil PD; Wright C; Manni A; Santner SJ
    Ann N Y Acad Sci; 1986; 464():126-37. PubMed ID: 3524346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of cytokines and sulphatase inhibitors in regulating oestrogen synthesis in breast tumours.
    Reed MJ; Purohit A; Duncan LJ; Singh A; Roberts CJ; Williams GJ; Potter BV
    J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):413-20. PubMed ID: 7626490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.
    Pasqualini JR; Chetrite GS
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):221-36. PubMed ID: 15860265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ estrogen production via the estrone sulfatase pathway in breast tumors: relative importance versus the aromatase pathway.
    Santner SJ; Feil PD; Santen RJ
    J Clin Endocrinol Metab; 1984 Jul; 59(1):29-33. PubMed ID: 6725522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of steroid sulfatase in local formation of estrogen in post-menopausal breast cancer patients.
    Nakata T; Takashima S; Shiotsu Y; Murakata C; Ishida H; Akinaga S; Li PK; Sasano H; Suzuki T; Saeki T
    J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):455-60. PubMed ID: 14623544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of estrogen synthesis in postmenopausal women.
    Purohit A; Reed MJ
    Steroids; 2002 Nov; 67(12):979-83. PubMed ID: 12398994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients.
    Pasqualini JR; Chetrite G; Blacker C; Feinstein MC; Delalonde L; Talbi M; Maloche C
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1460-4. PubMed ID: 8636351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New development in intracrinology of breast carcinoma.
    Sasano H; Suzuki T; Nakata T; Moriya T
    Breast Cancer; 2006; 13(2):129-36. PubMed ID: 16755106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentrations of estrone, estradiol and their sulfates, and evaluation of sulfatase and aromatase activities in patients with breast fibroadenoma.
    Pasqualini JR; Cortes-Prieto J; Chetrite G; Talbi M; Ruiz A
    Int J Cancer; 1997 Mar; 70(6):639-43. PubMed ID: 9096642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of 17beta-hydroxysteroid dehydrogenases and other estrogen-metabolizing enzymes in different cancer cell lines.
    Smuc T; Rizner TL
    Chem Biol Interact; 2009 Mar; 178(1-3):228-33. PubMed ID: 19022235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of aromatase and sulphatase in breast tumour cells.
    Purohit A; Wang DY; Ghilchik MW; Reed MJ
    J Endocrinol; 1996 Sep; 150 Suppl():S65-71. PubMed ID: 8943789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression level of enzymes related to in situ estrogen synthesis and clinicopathological parameters in breast cancer patients.
    Suzuki M; Ishida H; Shiotsu Y; Nakata T; Akinaga S; Takashima S; Utsumi T; Saeki T; Harada N
    J Steroid Biochem Mol Biol; 2009 Feb; 113(3-5):195-201. PubMed ID: 19159687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The selective estrogen enzyme modulators in breast cancer: a review.
    Pasqualini JR
    Biochim Biophys Acta; 2004 Jun; 1654(2):123-43. PubMed ID: 15172700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of estrogen concentrations, estrone sulfatase and aromatase activities in normal, and in cancerous, human breast tissues.
    Chetrite GS; Cortes-Prieto J; Philippe JC; Wright F; Pasqualini JR
    J Steroid Biochem Mol Biol; 2000; 72(1-2):23-7. PubMed ID: 10731634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of aromatase activity in breast fibroblasts by tumor necrosis factor alpha.
    Macdiarmid F; Wang D; Duncan LJ; Purohit A; Ghilchick MW; Reed MJ
    Mol Cell Endocrinol; 1994 Dec; 106(1-2):17-21. PubMed ID: 7895904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen and androgen-converting enzymes 17β-hydroxysteroid dehydrogenase and their involvement in cancer: with a special focus on 17β-hydroxysteroid dehydrogenase type 1, 2, and breast cancer.
    Hilborn E; Stål O; Jansson A
    Oncotarget; 2017 May; 8(18):30552-30562. PubMed ID: 28430630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen synthesis by osteoblast cell lines.
    Purohit A; Flanagan AM; Reed MJ
    Endocrinology; 1992 Oct; 131(4):2027-9. PubMed ID: 1396346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of progestins on breast tissue enzymes.
    Pasqualini JR
    Maturitas; 2003 Dec; 46 Suppl 1():S45-54. PubMed ID: 14670645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.